BetterLife Pharma Inc Market Cap ($5.42 Million)
Market Cap & Net Worth: BetterLife Pharma Inc (NPAU)
BetterLife Pharma Inc market cap. BetterLife Pharma Inc (F:NPAU) has a market capitalization of $5.42 Million (€4.64 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #28344 globally and #2440 in its home market, demonstrating a 117.74% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BetterLife Pharma Inc's stock price €0.07 by its total outstanding shares 161787023 (161.79 Million). Also see BetterLife Pharma Inc cash flow conversion for how efficiently the company converts equity into cash flow.
BetterLife Pharma Inc Market Cap History (2018–2026)
BetterLife Pharma Inc market cap history from 2018 to 2026. Data shows change from $289.39 Million to $12.77 Million (-45.31% CAGR). Check NPAU stock price for real-time trading data and today's change.
BetterLife Pharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BetterLife Pharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of BetterLife Pharma Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NPAU by Market Capitalization
Companies near BetterLife Pharma Inc in the global market cap rankings as of November 4, 2026. Also see NPAU total asset value for a full breakdown of the balance sheet.
Key companies related to BetterLife Pharma Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of BetterLife Pharma Inc (2018–2026)
Market capitalization of BetterLife Pharma Inc from 2018 to today. Between 2018 and today, BetterLife Pharma Inc's market cap moved from $289.39 Million to $ 12.77 Million, with a yearly change of -45.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €12.77 Million | +285.71% |
| 2025 | €3.31 Million | -72.22% |
| 2024 | €11.92 Million | +20.00% |
| 2023 | €9.93 Million | -51.12% |
| 2022 | €20.31 Million | -29.34% |
| 2021 | €28.75 Million | -88.40% |
| 2020 | €247.78 Million | +44.75% |
| 2019 | €171.18 Million | -40.85% |
| 2018 | €289.39 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of BetterLife Pharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.42 Million USD |
| MoneyControl | $5.42 Million USD |
| MarketWatch | $5.42 Million USD |
| marketcap.company | $5.42 Million USD |
| Reuters | $5.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BetterLife Pharma Inc
BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company's products pipeline includes BETR-001 for the t… Read more